CC

Claritev Corporation

CTEV·NYSE

$27.75

-2.1%
HealthcareMedical - Healthcare Information Services

Claritev Corporation, together with its subsidiaries, provides data analytics and technology-enabled cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company offers analytics-based services that reduce medical costs, through data-driven algorithms and insights that detect claims over-charges and negotiate or recommend reimbursement; and network-based services that provide contracted discounts with healthcare providers, as well as outsourced network development and management services. It provides payment and revenue integrity services, such as identifying and removing improper and unnecessary charges paid during the claim, as well as services to identify and help restore and preserve underpaid premium dollars. In addition, the company offers data and decision science services including a suite of solutions that apply modern methods of data science to produce descriptive, predictive, and prescriptive analytics that drive optimized benefit plan design, support decision-making, improve clinical outcomes, and reduce the total cost of care; and business-to-business healthcare payments and other services. It serves national and regional insurance companies, Blue Cross and Blue Shield plans, provider-sponsored and independent health plans, TPAs, self-insured health plans, property and casualty insurers, bill review companies, and other companies involved in the claim adjudication process. The company was formerly known as MultiPlan Corporation and changed its name to Claritev Corporation in February 2025. Claritev Corporation was founded in 1980 and is headquartered in New York, New York.

At a Glance

Live Snapshot
Market Cap$473.08M
EPS-17.3000
P/E Ratio-1.60
Earnings Date08/05/2026

ctev

Total Liabilities and Equity

Last Annual Value

4.89B

3-Year CAGR

-13%

5-Year CAGR

-10%

10-Year CAGR

-5%

CC

Claritev Corporation Competitors Analysis of Total Liabilities and Equity

CTEV · NYSE
CompanyTotal Liabilities and Equity
CAGR 3Y
CAGR 5Y
CAGR 10Y
4.89B
-11.1%-9.9%N/A 
1.90B
-10.8%6.0%4.7%
LFMD logo
LifeMD, Inc.
NASDAQ:LFMD
70.41M
6.4%7.1%56.7%
530.92M
43.6%22.8%46.9%
AXGN logo
AxoGen, Inc.
NASDAQ:AXGN
221.69M
4.0%1.3%16.9%
3.60B
-1.6%-1.0%7.1%
416.89M
-9.7%-18.1%N/A
1.93B
-1.3%-4.2%-3.5%
1.40B
-4.0%-2.7%38.5%
108.78M
5.7%5.6%11.3%
CC

Claritev Corporation Fair Value Envelope

CTEV · NYSE

Our analysis suggests that CTEV has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $27.75, this represents a potential HIDDEN relative to our calculated worth for Claritev Corporation.

Intrinsic Value
Current Price: $27.75